Asset Details
Do you wish to reserve the book?
The new KV3.4 inhibitor BDS-I1-8 as a potential pharmacological opportunity in Alzheimer's disease therapy
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The new KV3.4 inhibitor BDS-I1-8 as a potential pharmacological opportunity in Alzheimer's disease therapy
Do you wish to request the book?
The new KV3.4 inhibitor BDS-I1-8 as a potential pharmacological opportunity in Alzheimer's disease therapy
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The new KV3.4 inhibitor BDS-I1-8 as a potential pharmacological opportunity in Alzheimer's disease therapy
2020
Publisher
Wolters Kluwer - Medknow,Medknow Publications & Media Pvt. Ltd,Division of Pharmacology, Department of Neuroscience,Reproductive and Dentistry Sciences, School of Medicine, Federico Ⅱ University of Naples, Napoli, Italy,Wolters Kluwer Medknow Publications
